The Effect of Nanofat Injection on Androgenetic Alopecia
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-50
SponsorAssiut University
About this trial
Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP
Eligibility criteria
Qualifiers
Adults (ages 18-50).
A clinical diagnosis of androgenetic alopecia confirmed by dermoscopy of both males and females.
No previous topical treatment used in the past 3 months.
Disqualifiers
Alopecia totalis and alopecia universalis.
Cicatricial alopecia.
Other causes of hair loss such as immunological disease.
Skin disease in the affected area.
Trial design
Treatments tested in this trial
- Minoxidil 5 %
- PRP injection
- Nanofat injection
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov